Cocrystal of Apixaban–Quercetin: Improving Solubility and Bioavailability of Drug Combination of Two Poorly Soluble Drugs
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cocrystal of Apixaban–Quercetin: Improving Solubility and Bioavailability of Drug Combination of Two Poorly Soluble Drugs
Authors
Keywords
-
Journal
MOLECULES
Volume 26, Issue 9, Pages 2677
Publisher
MDPI AG
Online
2021-05-06
DOI
10.3390/molecules26092677
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A new cocrystal of isoniazid-quercetin with hepatoprotective effect: The design, structure, and in vitro/in vivo performance evaluation
- (2020) Fang Liu et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Solid Polymer Electrolytes with Flexible Framework of SiO2 Nanofibers for Highly Safe Solid Lithium Batteries
- (2020) Jin Cui et al. Polymers
- The role of pH and dose/solubility ratio on cocrystal dissolution, drug supersaturation and precipitation
- (2020) Tatiane Cogo Machado et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Salt solvates of quinolones and oxicams: Theoretical computation, structural characterization and dissolution studies
- (2020) Ling-tai Jiao et al. JOURNAL OF MOLECULAR STRUCTURE
- Improving Compliance and Decreasing Drug Accumulation of Diethylstilbestrol through Cocrystallization
- (2019) Zhen Li et al. CRYSTAL GROWTH & DESIGN
- Enhanced breakdown strength of aligned-sodium-titanate- nanowire/epoxy nanocomposites and their anisotropic dielectric properties
- (2019) Siyu Chen et al. COMPOSITES PART A-APPLIED SCIENCE AND MANUFACTURING
- Differential Solution Behavior of the New API–API Co-Crystal of Tramadol–Celecoxib (CTC) versus Its Constituents and Their Combination
- (2019) Adriana Port et al. CRYSTAL GROWTH & DESIGN
- Hepatoprotective Cocrystals of Isoniazid: Synthesis, Solid State Characterization and Hepatotoxicity Studies
- (2019) Balwant Yadav et al. CRYSTAL GROWTH & DESIGN
- Asymmetric alicyclic amine-polyether amine molecular chain structure for improved energy storage density of high-temperature crosslinked polymer capacitor
- (2019) Siyu Chen et al. CHEMICAL ENGINEERING JOURNAL
- Effectiveness of a Fixed-Dose, Single-Pill Combination of Perindopril and Amlodipine in Patients with Hypertension: A Non-Interventional Study
- (2018) Susanne V. Fleig et al. ADVANCES IN THERAPY
- Drug–Drug Interaction Profile of the Fixed-Dose Combination Tablet Regimen Ledipasvir/Sofosbuvir
- (2018) Polina German et al. CLINICAL PHARMACOKINETICS
- Enhanced through-plane thermal conductivity of PTFE composites with hybrid fillers of hexagonal boron nitride platelets and aluminum nitride particles
- (2018) Chen Pan et al. COMPOSITES PART B-ENGINEERING
- Tadalafil–Malonic Acid Cocrystal: Physicochemical Characterization, pH-Solubility, and Supersaturation Studies
- (2018) Manishkumar R. Shimpi et al. CRYSTAL GROWTH & DESIGN
- Novel Salt Cocrystal of Chrysin with Berberine: Preparation, Characterization, and Oral Bioavailability
- (2018) Rongjian Sa et al. CRYSTAL GROWTH & DESIGN
- Enhanced delivery of fixed-dose combination of synergistic antichagasic agents posaconazole-benznidazole based on amorphous solid dispersions
- (2018) Camila Bezerra Melo Figueirêdo et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Investigation of the through-plane thermal conductivity of polymer composites with in-plane oriented hexagonal boron nitride
- (2018) Chen Pan et al. INTERNATIONAL JOURNAL OF HEAT AND MASS TRANSFER
- Co-crystal of Tramadol–Celecoxib in Patients with Moderate to Severe Acute Post-surgical Oral Pain: A Dose-Finding, Randomised, Double-Blind, Placebo- and Active-Controlled, Multicentre, Phase II Trial
- (2018) José López-Cedrún et al. Drugs in research & development
- The effects of pH, surfactant, ion concentration, coformer, and molecular arrangement on the solubility behavior of myricetin cocrystals
- (2018) Shuzhen Ren et al. Acta Pharmaceutica Sinica B
- An acetonitrile-solvated cocrystal of piroxicam and succinic acid with co-existing zwitterionic and non-ionized piroxicam molecules
- (2018) Xiaojiao Liu et al. Acta Crystallographica Section C-Structural Chemistry
- Synthesis of regioselectively acylated quercetin analogues with improved antiplatelet activity
- (2017) Yu Duan et al. Molecular Medicine Reports
- Drug–Drug Multicomponent Crystals as an Effective Technique to Overcome Weaknesses in Parent Drugs
- (2016) Okky Dwichandra Putra et al. CRYSTAL GROWTH & DESIGN
- Improving the Solubility and Bioavailability of Apixaban via Apixaban–Oxalic Acid Cocrystal
- (2016) Yong Chen et al. CRYSTAL GROWTH & DESIGN
- Fixed-Dose Combination Therapy With Daclatasvir, Asunaprevir, and Beclabuvir for Noncirrhotic Patients With HCV Genotype 1 Infection
- (2015) Fred Poordad et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre study
- (2014) Thomas D Giles et al. LANCET
- Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial
- (2013) Eric Lawitz et al. LANCET
- Challenges and Opportunities in Achieving Bioequivalence for Fixed-Dose Combination Products
- (2012) Amitava Mitra et al. AAPS Journal
- New formulation approaches to improve solubility and drug release from fixed dose combinations: Case examples pioglitazone/glimepiride and ezetimibe/simvastatin
- (2012) Thomas Taupitz et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Dual Roles of Quercetin in Platelets: Phosphoinositide-3-Kinase and MAP Kinases Inhibition, and cAMP-Dependent Vasodilator-Stimulated Phosphoprotein Stimulation
- (2012) Won Jun Oh et al. Evidence-based Complementary and Alternative Medicine
- Apixaban for Extended Treatment of Venous Thromboembolism
- (2012) Giancarlo Agnelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Role of the fixed-dose combination lercanidipine–enalapril in renal protection
- (2011) Colin Gerard Egan et al. JOURNAL OF NEPHROLOGY
- Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome
- (2011) John H. Alexander et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial
- (2010) Antoinette K Tshefu et al. LANCET
- Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial
- (2010) George L Bakris et al. LANCET
- Understanding and Predicting the Effect of Cocrystal Components and pH on Cocrystal Solubility
- (2009) Sarah J. Bethune et al. CRYSTAL GROWTH & DESIGN
- The role of solvent in mechanochemical and sonochemical cocrystal formation: a solubility-based approach for predicting cocrystallisation outcome
- (2008) Tomislav Friščić et al. CRYSTENGCOMM
- Apixaban Metabolism and Pharmacokinetics after Oral Administration to Humans
- (2008) N. Raghavan et al. DRUG METABOLISM AND DISPOSITION
- Ethyl-paraben and nicotinamide mixtures: Apparent solubility, thermal behavior and X-ray structure of the 1:1 co-crystal
- (2008) S. Nicoli et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Apixaban, an oral, direct and highly selective factor Xa inhibitor:in vitro, antithrombotic and antihemostatic studies
- (2008) P. C. WONG et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More